A class action lawsuit was filed against the pharmaceutical company GlaxoSmithKline for allegedly promoting Paxil®, an antidepressant drug, for use by children and adolescents while withholding negative information about the medication's safety and effectiveness.
The class filed in Edwardsville, Illinois seeks to include all US residents who bought Paxil® or Paxil CR® for their children.
Madison County Associate Judge Ralph Mendelsohn has approved a $63.8 million class action settlement. GlaxoSmithKline denies the lawsuit's claims, but has agreed to pay to settle the claims.
This case was reported to the press on November 1, 2006. We will follow the progress and see if the pharmaceutical company dispenses its words.